Stamford, Conn., June 10, 2021 – Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application for the vial dosage form of nalmefene hydrochloride injection. Injectable nalmefene, an opioid...
STAMFORD, Conn. – [May 3, 2021] – Purdue Pharma L.P. today announced that the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) has approved, among other things, the adequacy of Purdue’s disclosure statement (the “Disclosure...
Plan will create National Opioid Abatement Trust Plan will make more than $10 billion in value available for opioid abatement programs across the country 100% of Purdue’s assets will be transferred to a new company dedicated at its core to addressing the opioid crisis...
STAMFORD, Conn. – March 1, 2021 – Purdue Pharma L.P. (“Purdue”) today announced the appointment of former Montana Governor Steve Bullock as Monitor to report quarterly to the Bankruptcy Court and Purdue’s board on the company’s compliance with its voluntary...
-- Agreement resolves DOJ investigations into past marketing practices -- Settlement funds primarily directed to state, local and tribal governments for opioid crisis abatement purposes -- Agreement brings Purdue closer to its ultimate goal of delivering more than $10...
-- 80 percent of students in Purdue Pharma’s sponsored regions reported they felt prepared to avoid prescription drug misuse after completing the course -- In response to an increase in distance learning, Prescription Drug Safety course is now available outside of...
When you access any of our websites, related other parities’ websites, mobile applications, or any electronic service, we may use cookies and other technologies to automatically collect information regarding you and your device to assess user activity and preferences. We may also use third-party analytic tools to assist with the collection of information including, but not limited to, Google Analytics. By using this site, you agree to our use of these technologies in accordance with our Privacy Policy.Ok
Privacy Policy Updates
Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parities’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.
